Clinical trial
Randomized, Double-Blind, Multi-Center Study of Cefepime/AAI101 in Hospitalized Adults With Complicated Urinary Tract Infections, Including Acute Pyelonephritis
NCT03680612 is registered in ClinicalTrials.gov with Allecra as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-Blind, Multi-Center Study of Cefepime/AAI101 in Hospitalized Adults With Complicated Urinary Tract Infections, Including Acute Pyelonephritis
- Lead sponsor
- Allecra
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 5, 2017
- Completion date
- February 14, 2018
- Enrollment
- 45 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.